| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q3 | Sep 30, 2025 | ACATIS Investment | - | -0.2% | 300750.SZ, 6920.T, 9988.HK, CLS, CRM, HAL, HIMS, ICE, ISRG, KGHM.WA, KRN.DE, KVN, LRCX, PEP, TSM, UMI.BR, UNH, UPWK, VNA.DE, ZAL.DE | AI, Argentina, energy, global, Reform, semiconductors, technology | AI infrastructure continues to drive strong performance in semiconductor equipment manufacturers like Lam Research, Lasertec, and TSMC. Companies are benefiting from sustained AI demand with TSMC maintaining technological leadership and pricing power in the AI supply chain. Salesforce has reduced workforce due to AI reducing labor requirements, which the manager views positively. | UPWK UMI BB PEP KGH PW HIMS HAL ZAL GR CLS CN SNPS HOLX ICE KRN GR 2330 TT |
View |
| 2025 Q2 | Jul 4, 2025 | Maple Tree Capital – Jonagold | 42.3% | - | DNUT, GRND, HIMS, LMND, NBIS, UPST | AI, Concentration, Fintech, growth, small caps, technology, volatility | Upstart's AI underwriting capabilities are central to the investment thesis, with the manager attending AI Day and emphasizing how AI improvements drive better credit decisions and expanding product offerings. The AI models are becoming more accurate and comprehensive while reducing business volatility. | GRDR HIMS LMND UPST GRND LMND |
View |
| 2025 Q2 | Jul 4, 2025 | Maple Tree Capital – Heartwood | 26.3% | - | DNUT, GRND, HIMS, LMND, MCD, UPST | AI, Concentration, conviction, Fintech, growth, small caps, technology, volatility | Upstart's AI underwriting capabilities are central to the investment thesis, with the manager attending AI Day and emphasizing how AI models improve with more data collection. The company's AI has grown more accurate, comprehensive and adaptive, reducing business volatility through better credit assessment. | GRDR LMND UPST |
View |
| 2025 Q2 | Jul 24, 2025 | Voya Small Company Fund | - | - | HIMS, MGNI, MUR, NSP, NVT, RKLB | AI, growth, healthcare, industrials, small cap, technology, value | The technology sector surged in 2Q25, driven by artificial intelligence growth as hyperscalers increased capital expenditure and improved ways to profit from their AI investments. The communication services sector also saw strong gains, benefiting from AI advancements and robust earnings. | View | |
| 2024 Q2 | Jul 10, 2024 | Mountain Vista Wealth Management | - | - | 300750.SZ, 6920.T, 9988.HK, CLS, CRM, HAL, HIMS, ICE, ISRG, KGHM.WA, KRN.DE, KVUE, LRCX, PEP, TSM, UMI.BR, UNH, UPWK, VNA.DE, ZAL.DE | AI, Argentina, Energy Transition, global, healthcare, semiconductors, technology, value | AI infrastructure continues driving strong performance across semiconductor equipment manufacturers like Lam Research, Lasertec, and TSMC. Companies are benefiting from sustained AI demand with TSMC maintaining technological leadership and pricing power in the AI supply chain. Salesforce has reduced workforce due to AI reducing labor requirements, viewed positively by the manager. | View | |
| 2025 Q2 | Jun 30, 2025 | Airlie Australian Share Fund | - | - | 300750.SZ, 6920.T, 9988.HK, CLS, CRM, HAL, HIMS, ICE, ISRG, KGHM.WA, KRN.DE, KVUE, LRCX, PEP, TSM, UMC.PA, UNH, UPWK, VNA.DE, ZAL.DE | AI, China, energy, Germany, healthcare, semiconductors, value | AI infrastructure continues driving strong performance across semiconductor equipment manufacturers and data center suppliers. Companies like Lam Research, TSMC, and Bloom Energy are benefiting from continued AI expansion, with Bloom Energy securing potentially its largest project for a 900 MW power plant to supply AI data centers. | View | |
| 2025 Q1 | Apr 9, 2025 | Maple Tree Capital – Heartwood | -18.0% | -18.0% | ASO, CRWD, DNUT, EA, GRND, HIMS, LMND, LYFT, RDDT, UEC, UPST | AI, growth, nuclear, small caps, tariffs, technology, volatility | President Trump launched sweeping tariffs on countries worldwide, catching markets off guard and sparking panic. These tariffs pose serious inflationary threats and have created a lose-lose scenario for the Fed. The manager views these extreme tariffs as partly a negotiating tactic but acknowledges justified market fear. | RDDT LYFT CRWD EA UEC ASO DNUT UPST |
View |
| 2025 Q1 | Apr 9, 2025 | Maple Tree Capital – Jonagold | -13.6% | -13.6% | ASO, CRWD, DNUT, EA, GRDR, HIMS, LMND, LYFT, RDDT, UEC, UPST | AI, Concentration, cybersecurity, growth, nuclear, tariffs, technology, volatility | Upstart's latest AI model enhancements, including m18 and m19, set the company up well to execute in the newly unfavorable environment. Electronic Arts has consistently invested more in R&D than its peers, positioning itself to lead in the AI-driven future of gaming. Reddit holds incredibly unique and structured user-generated data, which will be extremely valuable in the AI era. | RDDT LYFT CRWD EA UEC ASO DNUT UPST |
View |
| 2025 Q1 | Apr 5, 2025 | Cedar Grove Capital Management | 0.4% | 0.4% | ALC, HIMS, LNSR, TLT | healthcare, Multi-Strategy, Short Selling, small caps, special situations, Trade Policy | Trump administration's tariff implementation has created unprecedented market uncertainty and negative economic impacts. Manager notes tariffs were expected to be negotiation tactics but have become permanent policy, causing market drawdowns and forcing strategy adjustments. | LNSR HIMS |
View |
| 2025 Q1 | Apr 5, 2025 | ClearBridge Investments Small Cap Growth Strategy | - | - | ARCH, BJ, CNMD, CWAN, ELF, FOUR, GERN, GKOS, GLBE, HE, HIMS, INTA, ITCI, KVYO, PYCR, RBC, RKLB, TNC, VRNS, WIX | AI, Biotech, growth, small cap, stock selection, Trade Policy, volatility | The DeepSeek model architecture caused investors to question potential returns on investment and monetization of generative AI initiatives, leading to air coming out of the sector-crossing narrative and investment tailwind around generative AI. The combination of concerns around AI reporting precipitated a meaningful pullback in stocks. | GERN HIMS ARCH RKLB GKOS |
View |
| 2026 Q1 | Apr 10, 2026 | Cedar Grove Capital Management | -23.0% | -23.0% | ABVX, EVLV, HIMS, KITS.TO, LNSR, MTY.TO, NKTR, OSW, REAL, SNWV, TOI, WW | Biotechnology, consumer, healthcare, Long/Short, Multi-Strategy, small cap, special situations | MTY.TO NKTR ABVX TOI SNWV EVLV REAL KITS.TO |
View | |
| 2025 Q1 | Mar 31, 2025 | Voya Small Company Fund | - | - | COHU, CORT, HIMS, MWA, PRA, SHOO | growth, healthcare, semiconductors, small caps, technology, value | The fund focuses on US small cap core equity strategy and outperformed the Russell 2000 Index during Q1 2025. Small caps experienced broader pullbacks compared to large caps, with the fund benefiting from stock selection in industrials, healthcare, and financials sectors. | MWA PRA HIMS |
View |
| 2025 Q1 | Mar 31, 2025 | Emerald Wealth Partners – Focused Equity Strategy | -3.6% | -3.6% | 300750.SZ, 6920.T, BABA, CLS, CRM, HAL, HIMS, ICE, ISRG, KGHM.WA, KRN.DE, KVUE, LRCX, PEP, TSM, UMC.PA, UNH, UPWK, VNA.DE, ZAL.DE | AI, Argentina, Germany, global, semiconductors, value | AI infrastructure driving strong performance in wafer equipment manufacturers and data center suppliers. Companies like Lam Research, TSMC, and Bloom Energy benefiting from AI expansion. Salesforce reducing workforce due to AI efficiency gains. | View | |
| 2023 Q1 | Mar 31, 2023 | PM Capital Global Companies Fund | 4.6% | 4.6% | 300750.SZ, 6920.T, 981.HK, 9988.HK, CLS, CRM, HAL, HIMS, ICE, ISRG, KRN.DE, KVUE, LRCX, PEP, TSM, UNH, UPWK, VNA.DE, ZAL.DE | AI, Argentina, Banking, Germany, Reform, semiconductors, technology | AI infrastructure continues to drive strong performance across semiconductor equipment manufacturers and data center companies. Lam Research, Lasertec, and TSMC all benefited from AI-driven demand, with TSMC maintaining technological leadership and pricing power in the AI supply chain. The fund added positions in companies benefiting from AI expansion including Bloom Energy for data center power supply and Celestica for AI infrastructure development. | View | |
| 2025 Q4 | Feb 4, 2026 | Carillon Eagle Small Cap Growth Fund | 0.0% | 0.0% | AROC, BE, BTSG, COHR, DY, ESAB, ESTA, EXR, GH, HIMS, ITRI, KKR, PJT, PRKS, RBA, RMBS, VRNS, WWD | aerospace, AI, cyclicals, growth, healthcare, Onshoring, small cap, technology | The AI investment cycle accelerated notably in 2025 and is expected to continue driving the market early in 2026. Bottlenecks from power supply availability remain a key gating factor to bring new computing capacity online. Despite widespread calls that AI stocks are in bubble territory, the managers hold a balanced view and believe investor skepticism may prove supportive of a prolonged investment cycle. Healthcare remains the largest sector in the US with total expenditures reaching $5 trillion and accounting for 17.7% of GDP. The sector has been working off excesses from the COVID-19 pandemic but shows reasons for optimism including increased M&A activity and more favorable valuations. Interest in healthcare stocks could see a resurgence once investors are comfortable with policy and regulatory overhangs. Aerospace stocks have largely outperformed as production challenges at two global aircraft manufacturers have led to sustained increases in high-margin aftermarket parts and services. With manufacturers finally resolving longstanding production issues, original equipment exposed stocks could potentially outperform aftermarket-exposed stocks as aircraft production rates ramp up. Re-shoring and factory automation are expected to emerge as key themes driving broader capital spending in 2026. This represents a significant shift in manufacturing and investment patterns as companies bring operations back to the United States. | View | |
| 2025 Q4 | Feb 22, 2026 | Unconventional Value | 0.0% | 0.0% | AMZN, HIMS, PGY, PL, RELY, SPIR, THRY, UPST, WISE.L, WU, XMTR | AI, Fintech, growth, SaaS, Satellites, small cap, technology, value | AI is viewed as a technology enabler that will accelerate product development and create tailwinds for existing businesses rather than replace human judgment. The manager believes AI will never replace human judgment and sees it as enhancing rather than disrupting core investment strategies. Planet's satellite constellation and daily Earth imaging capability represents a unique infrastructure play. The manager believes Planet is building the default system of record for monitoring Earth, with the daily scan providing infinitely scalable data distribution at zero marginal cost. Remitly's digital remittance platform is taking market share from legacy players like Western Union. The business model relies on acquiring customers via digital channels and earning fees on repeat transactions, with scale benefits improving economics over time. Thryv represents a business model transition from legacy marketing services to SaaS, targeting small businesses moving up-market. The strategy focuses on converting legacy customers to the SaaS platform and expanding functionality for larger businesses with more complex needs. | RELY THRY PL |
View |
| 2025 Q3 | Oct 8, 2025 | Maple Tree Capital – Jonagold | -13.1% | - | ASO, CRWV, DNUT, GOOGL, GRND, HIMS, LMND, NBIS, PGR, SN, TSLA, UEC, UPST | AI, Concentration, conviction, growth, small caps, technology, volatility | The manager believes this AI-driven bull market remains in its long-term infancy, with deep capex spend by Big Tech companies signaling increased momentum. They see AI applications like Upstart and Lemonade becoming the next investment wave to build on top of infrastructure over the next 5 years. | GRND UPST |
View |
| 2025 Q3 | Oct 8, 2025 | Maple Tree Capital – Heartwood | 40.0% | - | ASO, CRWV, DNUT, GOOGL, GRND, HIMS, LMND, NBIS, PGR, SN, TSLA, UEC, UPST | AI, Concentration, Fintech, small caps, uranium, volatility | The manager believes this AI-driven bull market remains in its long-term infancy with deep capex spend by Big Tech companies signaling increased momentum. They see AI applications like Upstart and Lemonade becoming the next investment wave to build on top of infrastructure over the next 5 years. | UPST CRWV NBIS UEC |
View |
| 2025 Q3 | Oct 31, 2025 | Fairtree Wild Fig Multi Strategy Hedge Fund | 1.4% | - | 300750.SZ, 6920.T, 9988.HK, CLS, CRM, HAL, HIMS, ICE, ISRG, KGHM.WA, KRN.DE, KVUE, LRCX, PEP, TSM, UMI.BR, UNH, UPWK, VNA.DE, ZAL.DE | AI, energy, global, Reform, semiconductors, technology, value | AI infrastructure companies like Lam Research, TSMC, and Palantir benefited from continued strong expansion. Bloom Energy supports data center expansion with reliable power supply for AI infrastructure. Salesforce reduced workforce as artificial intelligence reduces labor requirements. | View | |
| 2025 Q3 | Oct 28, 2025 | AGT Partners | - | - | 300750.SZ, 6920.T, 9988.HK, CLS, CRM, HAL, HIMS, ICE, ISRG, KGHM.WA, KKR, KRN.DE, LRCX, PEP, TSM, UMI.BR, UNH, UPWK, VNA.DE, ZAL.DE | AI, Argentina, Energy Transition, Germany, global, semiconductors, value | AI infrastructure continues to drive strong performance across semiconductor equipment manufacturers like Lam Research, Lasertec, and TSMC. Companies are benefiting from sustained AI demand with TSMC maintaining technological leadership and pricing power in the AI supply chain. Salesforce has reduced workforce due to AI efficiency gains, viewed positively by the manager. | 6088 HK 6601 HK KKR APO |
View |
| 2025 Q3 | Oct 21, 2025 | Deep Sail Capital Partners | 5.8% | 18.1% | CLPT, HIMS, NURS.V, ONON, PNG.TO, QURE, VST.V, WSTL | Biotechnology, Bubble, defense, Gene Therapy, growth, small caps, Speculation, Telehealth | Hydreight Technologies represents a major position in the telehealth space, operating a vertically integrated mobile health platform combining SaaS technology with healthcare services. The company has experienced exceptional growth from $3 million in 2022 to over $100 million forecast in the next 12 months. VSDHOne platform enables consumer health brands to launch nationwide telehealth offerings in days, capitalizing on the trend following Hims & Hers' success. | View | |
| 2024 Q3 | Oct 1, 2024 | Maple Tree Capital – Heartwood | 2.4% | 0.0% | ADBE, ASO, CHGG, CRWD, DIS, GOOGL, GRND, HIMS, KKD, LMND, LYFT, RKLB, SMCI, SOUN, TSLA, UEC, UPST | AI, cybersecurity, growth, nuclear, Rideshare, small caps, turnaround, value | Initiated Crowdstrike after it fell ~40% following the July 19, 2024 tech outage. The manager viewed the outage as demonstrating Crowdstrike's power and moat, as the entire tech sector practically shut down. Despite fears of lawsuits and market share loss, analysts did not significantly revise earnings estimates, suggesting the impact was primarily multiple contraction. | View | |
| 2024 Q3 | Oct 1, 2024 | Maple Tree Capital – Jonagold | 32.7% | 0.0% | ADBE, ASO, CHGG, CRWD, DIS, DNUT, GOOGL, GRND, HIMS, LMND, LYFT, RKLB, SMCI, SOUN, TSLA, UEC, UPST | Fintech, growth, Rate Cuts, small caps, technology, turnaround | Jonagold strategically focuses on small-cap investments with substantial growth prospects that are temporarily out of favor due to cyclical trends or significantly misunderstood. The fund expects small caps to continue performing well as the Federal Reserve further reduces rates, with rate-sensitive securities front-loading near the end of Q3. | View | |
| 2025 Q4 | Jan 29, 2026 | Ashva Capital Management | 0.0% | 0.0% | AAPL, AMD, AMZN, COST, CSCO, DIS, GOOGL, HIMS, META, MU, NFLX, NVDA, PLTR, SPOT, UBER, WMT, ZG | AI, Compounding, long-term, Quality, semiconductors, technology, US, value | The manager discusses whether AI represents a bubble, comparing current valuations to traditional retailers like Costco and Walmart trading at higher forward P/E multiples than NVIDIA. He argues that we cannot be in an AI bubble when defensive stocks trade at higher multiples than leading AI companies. The discussion emphasizes that AI-driven demand is creating structural changes in memory and semiconductor markets. Memory semiconductors are highlighted as no longer being a commodity business driven by PC cycles, but rather a strategic input for AI, cloud infrastructure, and data-intensive workloads. The supply side has consolidated with fewer rational players, higher capital intensity, and better pricing discipline. Micron is positioned to benefit from AI-driven demand and improved industry structure. The manager emphasizes owning high-quality U.S. businesses that compound intrinsic value over time. He argues that obvious, high-quality businesses are not a failure of imagination but recognition of reality, as the modern internet economy rewards scale and dominant positions. Quality businesses can deliver asymmetric returns through duration of dominance. Valuation discipline is emphasized as critical to long-term success, with the manager noting that overpaying can cause long-term returns to go sideways. The portfolio deliberately avoided chasing narrow market leadership at elevated valuations, accepting short-term underperformance to preserve long-term risk-adjusted outcomes. Value creation comes from buying quality businesses at rational prices. | DIS AMD MU |
View |
| 2023 Q4 | Jan 28, 2024 | Highwood Value Partners | - | - | 300750.SZ, 6920.T, 9988.HK, CLS, CRM, HAL, HIMS, ICE, ISRG, KGHM.WA, KRN.DE, KVUE, LRCX, PEP, TSM, UMI.BR, UNH, UPWK, VNA.DE, ZAL.DE | AI, energy, global, healthcare, semiconductors, technology, value | AI infrastructure continues driving strong performance across semiconductor equipment manufacturers like Lam Research, Lasertec, and TSMC. Companies are benefiting from sustained AI demand with TSMC maintaining technological leadership and pricing power in the AI supply chain, while data center infrastructure providers like Celestica are gaining from cloud and AI infrastructure growth. | View | |
| 2025 Q4 | Jan 22, 2026 | ABS Global Investment | 0.0% | 0.0% | 0700.HK, 1810.HK, BABA, GME, HIMS | AI, Biotech, Decoupling, Global Markets, Mining, Rate Cuts, small caps, tariffs | AI stocks were among top performers despite high valuations, with momentum overcoming valuation concerns. Chinese DeepSeek caused temporary rotation but recovery was strong due to hyperscaler commitment to increased CAPEX spending. AI boom touched all regions with astronomical gains in memory chips and private LLM companies. Small cap performance varied by region with US Russell 2000 gaining 2.2% in Q4. Speculative stocks reversed significantly after strong Q3. European small caps showed value outperformance driven by lower rates and weakening dollar. Biotech sector gained 29% in Q4 with Russell 2000 Biotech up 75% since June. 2025 marked significant shift from US dominance to non-US strength driven by cheap valuations and tariff impacts. Tariffs triggered rally in domestic-oriented themes like European defense which gained over 100%. Emerging markets shrugged off tariff concerns with many top performers seeing limited impact from substantial tariff increases. Precious metals surge dominated Canadian small caps leading to best year since 2009 with MSCI Canada Small Cap up 54%. Mining stocks contributed two-thirds of index return and represent 43% of index heading into 2026. Australian mining also saw double-digit rally offsetting broad declines elsewhere. | View | |
| 2024 Q4 | Jan 2, 2025 | Cedar Grove Capital Management | 21.0% | 0.0% | AAPL, HIMS, MSTR, RCAT, SNBR | AI, crypto, Hedging, Multi-Strategy, Options, small caps, Telehealth, Trump | HIMS is the fund's second-largest holding with immense long-term potential in cash-pay telehealth. The manager navigated complex option strategies around FDA decisions on Tirzepatide and Semaglutide, ultimately protecting the position while maintaining conviction in the long-term thesis despite short-term volatility. | View | |
| 2024 Q2 | Jul 7, 2024 | Cedar Grove Capital Management | 21.0% | 0.0% | AAPL, AMZN, ANF, BIG, GOOGL, HIMS, LULU, META, MSFT, NVDA, TSLA, XPOF | AI, Banking, CRE, Long Term, retail, small cap, value | CRE continues to offload entire office buildings at fractions of what they paid for them just a few short years ago. This level of stress in the banking system continues to flash warning signs which have been going on for the last few years. Smaller banks with larger CRE exposure could face solvency issues. | View | |
| 2023 Q1 | Apr 17, 2023 | SandbrooK Capital | 6.0% | 11.1% | AMZN, BILL, BOX, CFLT, CRM, CROX, CRWD, ESTC, ETSY, GOOS, HCP, HIMS, MSFT, NKE, RH, SNAP, SNOW, SPT, VRT, ZM | consumer, Long/Short, Macro, risk management, software, technology | Manager focused on large cap tech and growth software names, particularly beaten-up tech stocks in January. Positioned in CRM, CRWD, ZM, SNOW, BILL, AMZN, MSFT, and ESTC as top contributors. Also shorted tier 2 high growth software names where multiples had run above long-term averages. | SONO |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| May 12, 2026 | Seeking Alpha | Seeking Alpha | Hims & Hers Health, Inc. | Healthcare | Telehealth | Bull | New York Stock Exchange | digital healthcare, Eli Lilly, GLP-1, Hims & Hers Health, international expansion, margin pressure, Novo Nordisk, Revenue Growth, short interest, telehealth | View Pitch |
| Apr 27, 2026 | Substack | Shareholders Unite | Hims & Hers | Healthcare | Telehealth | Bull | New York Stock Exchange | GLP-1 medications, growth strategy, Hims & Hers, international expansion, JP Morgan, Novo Nordisk, Product Diversification, regulatory trends, short interest, telehealth | View Pitch |
| Apr 20, 2026 | Substack | Shareholders Unite | Hims & Hers | Healthcare | Telehealth | Bull | New York Stock Exchange | Eucalyptus acquisition, Hims & Hers, international expansion, Novo Nordisk, peptide restrictions, Personalized healthcare, Revenue Growth, Strategic Partnerships, Subscriber Base, telehealth | View Pitch |
| Apr 15, 2026 | Seeking Alpha | Seeking Alpha | Hims & Hers Health, Inc. | Healthcare | Telemedicine | Bull | New York Stock Exchange | diagnostic lab testing, Eucalyptus acquisition, GLP-1 medications, healthcare, Hims & Hers, international expansion, Novo Nordisk partnership, profitability, Revenue Growth, telemedicine | View Pitch |
| Apr 13, 2026 | Fund Letters | Cedar Grove Capital Management | Hims and Hers Health | Health Care | Health Care Technology | Bear | NYSE | Bear, Healthcare Technology, Options Strategy, risk management, Short Position, telehealth | View Pitch |
| Apr 13, 2026 | Fund Letters | ClearBridge Investments Small Cap Growth Strategy | Hims & Hers Health Inc | Health Care | Health Care Technology | Bull | NYSE | brand recognition, Consumer-health, digital health, Healthcare IT, Profitability Improvement, Revenue Growth, telehealth | View Pitch |
| Apr 13, 2026 | Fund Letters | Voya Small Company Fund | Hims & Hers Health Inc | Health Care | Health Care Technology | Bull | NYSE | Consumer healthcare, digital health, growth, Healthcare Technology, SaaS, telehealth | View Pitch |
| Apr 13, 2026 | Fund Letters | Maple Tree Capital - Jonagold | Hims & Hers Health | Health Care | Health Care Services | Neutral | NYSE | covered calls, Momentum Stock, Options trading, telehealth, Volatility | View Pitch |
| Mar 16, 2026 | Substack | Shareholders Unite | Hims & Hers Health, Inc. | Healthcare | Telehealth | Neutral | New York Stock Exchange | digital health, Eucalyptus acquisition, international expansion, Menopause treatment, Personalized healthcare, regulatory challenges, subscription model, telehealth, Testosterone support, weight management | View Pitch |
| Feb 26, 2026 | Fund Letters | Dr. Hendrik Leber | Hims & Hers Health, Inc. | Health Care | Health Care Technology | Bull | New York Stock Exchange | international expansion, profitability, recurring revenue, Subscription, telemedicine | View Pitch |
| Feb 4, 2026 | Twitter / X | @A_May_MD | Hims & Hers Health, Inc. | Pharmaceuticals, Biotechnology & Life Sciences | Biotechnology | Bear | New York Stock Exchange | ChronicCare, CompoundDrugs, Digitalhealth, Glp1, HealthcareServices, telehealth, telemedicine | View Pitch |
| Jan 29, 2026 | Seeking Alpha | Seeking Alpha | Hims & Hers Health, Inc. | Healthcare | Telehealth | Bull | New York Stock Exchange | acquisition, e-health, gross margins, international expansion, investment strategy, market opportunities, Revenue Growth, Subscriber Growth, telehealth, valuation | View Pitch |
| Jan 23, 2026 | Twitter / X | @cedargrovecm | Hims & Hers Health, Inc. | Health Care Services | Health Care Technology | Bear | New York Stock Exchange | FDA, Glp, HIMS, Marketing Software, Our, Over Indexing, Play, Shortage | View Pitch |
| Jan 23, 2026 | Twitter / X | @OddDiligence | Hims & Hers Health, Inc. | Health Care Services | Health Care Technology | Bear | New York Stock Exchange | Chip Packaging, Glp, HIMS, Liraglutide, Marketing Software, Non Glp, semaglutide, Semaglutide Liraglutide | View Pitch |
| Jan 23, 2026 | Twitter / X | @DataDInvesting | Hims & Hers Health, Inc. | Health Care Services | Health Care Providers & Services | Bull | New York Stock Exchange | FCF margin, Get, Get Revenue, HIMS, Retaining, Retaining Customers, telehealth, Wellness | View Pitch |
| Jan 17, 2026 | Seeking Alpha | Seeking Alpha | Hims & Hers Health, Inc. | Healthcare | Telehealth | Neutral | New York Stock Exchange | Andrew Dudum, compounded semaglutide, Eli Lilly, international expansion, lab testing, Novo Nordisk, preventive care, telehealth, visionary leadership, weight-loss drugs | View Pitch |
| Jan 8, 2026 | Seeking Alpha | Seeking Alpha | Hims & Hers Health, Inc. | Health and Wellness | Health and Wellness | Bull | New York Stock Exchange | clinical lab services, health and wellness, Home-Testing, international expansion, market undervaluation, Preventative Testing, Revenue Growth, Share Buyback, Subscriber Base, telehealth | View Pitch |
| Jan 8, 2026 | Seeking Alpha | Seeking Alpha | Hims & Hers Health, Inc. | Health and Wellness | Health and Wellness | Bull | New York Stock Exchange | clinical lab services, healthcare solutions, Hims & Hers Health, international expansion, market undervaluation, online health platform, product launches, revenue target, Share Buyback, Subscriber Growth | View Pitch |
| Sep 16, 2025 | Short Thesis | Spruce Point | Hims & Hers Health Inc | Consumer Staples | Health Care Technology | Bear | NYSE | CAC, growth, Prescriptions, Regulation, telehealth | View Pitch |
| Sep 16, 2025 | Short Thesis | Hunterbrook | Hims & Hers Health Inc | Consumer Staples | Health Care Providers & Services (Digital Health) | Bear | NYSE | CAC, Churn, Regulation, Subscriptions, telehealth | View Pitch |
| Aug 13, 2025 | Seeking Alpha | Louis Gerard | Hims & Hers Health, Inc. | Consumer Staples | Household & Personal Products | Neutral | NYSE | — | View Pitch |
| Aug 13, 2025 | Seeking Alpha | JR Research | Hims & Hers Health, Inc. | Consumer Staples | Household & Personal Products | Bear | NYSE | — | View Pitch |
| Aug 13, 2025 | Seeking Alpha | Infinity Curve | Hims & Hers Health, Inc. | Consumer Staples | Household & Personal Products | Bull | NYSE | — | View Pitch |
| Aug 8, 2025 | Seeking Alpha | Analysis Fundamental | Hims & Hers Health | Consumer Staples | Household & Personal Products | Bull | NYSE | — | View Pitch |
| Aug 7, 2025 | Seeking Alpha | Alpha Line | Hims & Hers Health, Inc. | Consumer Staples | Household & Personal Products | Bull | NYSE | — | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||